CISCRP: Supporting Patient Diversity Campaign

Suzanne H.

Suzanne H.

Sales and Marketing

Clincierge is supporting the importance of patient diversity in clinical trials.

We are proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S. We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone. 

CISCRP patient diversity campaign

View the campaign and full-page educational spread here.

We collaborated with CISCRP to sponsor an educational advertisement published in 5 different newspaper publications, print and digital, reaching over 3 million diverse individuals across various communities. The campaign highlights the critical importance of diversity among participants in clinical studies to find medications that are effective for all populations. The full-page educational spread is distributed via print and digital channels reaching more than 3 million individuals in the Black, African American, Hispanic, and Latino communities.

We invite you to share this educational spread and to learn more about CISCRP’s International Education and Media Awareness Campaigns here.

Patient diversity in clinical trials is an ongoing effort across the industry. Each stakeholder is responsible for ensuring the safety of both the trial process and the resulting treatment for all involved. Clincierge aligns our services to support the needs of diverse populations. For us, this commitment to diversity begins at home. Clincierge fosters diversity, equity, and inclusion in all aspects of our company culture, and our Diversity, Equity, and Inclusion Committee continue to create opportunities for education and celebration.

Contact us today to learn how Clincierge can support patient diversity and inclusion in your upcoming clinical trials.

We are monitoring the impact of the COVID-19 Delta Variant on the travel and clinical trial industries.